Skip to main content

Agitation News (Page 4)

Most PCPs Do Not Feel Comfortable Screening for Firearm Safety

THURSDAY, Sept. 21, 2023 – Only a minority of internal medicine (IM) providers report feeling comfortable conducting routine firearm safety screening, according to a study published online Aug. 31...

Gun Injuries Rise as Neighborhoods Gentrify

THURSDAY, Sept. 21, 2023 – As working class neighborhoods gentrify, you'll likely see rents rise, pricey restaurants move in — and maybe also a rise in gunshot wounds, researchers say. In U.S. n...

Few Doctors, Spotty Internet: Finding Mental Health Care Tough for Many Americans

WEDNESDAY, Sept. 20, 2023 – Nearly one in five counties across the United States lack psychiatrists or internet service, making it difficult for around 10.5 million Americans to find mental health...

Doctors Often Wary of Asking Patients About Guns in the Home

MONDAY, Sept. 18, 2023 – It's an important health topic, but both adult patients and their primary care doctors shy away from discussing firearms and gun safety, a new survey finds. While they may...

Tobacco, Cannabis Use Tied to High Rates of Self-Reported Mental Health Issues

FRIDAY, Sept. 15, 2023 – Use of tobacco and/or cannabis, particularly co-use of both substances, is associated with poor mental health, according to a study published online Sept. 13 in PLOS ONE....

MDMA/Ecstasy Shows Even More Promise in Easing PTSD

THURSDAY, Sept. 14, 2023 – A new study is adding to evidence that the party drug "ecstasy" can boost the benefits of talk therapy for people suffering from post-traumatic stress disorder (PTSD). In...

Recurrent Injury, Death Common After Acute Firearm Injury

THURSDAY, Aug. 31, 2023 – Recurrent injury and death are common among acutely firearm-injured patients in the United States, according to a study published online Aug. 29 in the Annals of Internal...

USPSTF: Evidence Lacking for Interventions in Prevention of Child Maltreatment

TUESDAY, Aug. 29, 2023 – The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is inadequate for assessing the balance of benefits and harms of primary care interventions for...

2019 to 2022 Saw Increase in Mental Health Service Use, Spending

MONDAY, Aug. 28, 2023 – From 2019 to 2022, there was a considerable increase in mental health service utilization and spending, according to a research letter published online Aug. 25 in JAMA Health...

Your Teen & Social Media: Experts Offer Tips to Parents

MONDAY, July 31, 2023 – When parents meet U.S. Surgeon General Dr. Vivek Murthy, one concern comes up time after time. "The most common question parents ask me is: 'Is social media safe for my...

AHA News: Is Venting Good For Your Health?

FRIDAY, July 28, 2023 (American Heart Association News) – Venting – the release of negative, pent-up emotions – can feel good. But is it actually good for you? Or does it do more harm than good to dw...

FDA Approves Igalmi (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults

NEW HAVEN, Conn., April 06, 2022 (GLOBE NEWSWIRE) – BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop...

FDA Approves Adasuve (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults

MOUNTAIN VIEW, Calif., Dec. 21, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Adasuve (loxapine) Inhalation Powder 10 mg ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Agitated State

Related drug support groups

citalopram, olanzapine, risperidone